This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2020 Sep 17;383(12):1193.

doi: 10.1056/NEJMc2023284.

Liraglutide for Adolescents with Obesity

Justin Z Amarin¹, Aladdin S Dahbour¹, Ayman A Zayed¹

Affiliations

PMID: 32937056
DOI: 10.1056/NEJMc2023284

Comment

Liraglutide for Adolescents with Obesity

Justin Z Amarin et al. N Engl J Med. 2020.

. 2020 Sep 17;383(12):1193.

doi: 10.1056/NEJMc2023284.

Authors

Justin Z Amarin¹, Aladdin S Dahbour¹, Ayman A Zayed¹

Affiliation

¹ University of Jordan School of Medicine, Amman, Jordan baraaayman@gmail.com.

PMID: 32937056
DOI: 10.1056/NEJMc2023284

No abstract available

PubMed Disclaimer

Comment in

Liraglutide for Adolescents with Obesity. Reply.
Kelly AS, Hale PM. Kelly AS, et al. N Engl J Med. 2020 Sep 17;383(12):1193-1194. doi: 10.1056/NEJMc2023284. N Engl J Med. 2020. PMID: 32937058 No abstract available.

Comment on

A Randomized, Controlled Trial of Liraglutide for Adolescents with Obesity.
Kelly AS, Auerbach P, Barrientos-Perez M, Gies I, Hale PM, Marcus C, Mastrandrea LD, Prabhu N, Arslanian S; NN8022-4180 Trial Investigators. Kelly AS, et al. N Engl J Med. 2020 May 28;382(22):2117-2128. doi: 10.1056/NEJMoa1916038. Epub 2020 Mar 31. N Engl J Med. 2020. PMID: 32233338 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information